Gallbladder Cancer
📧 Sign up to get email alerts when something new happens for Gallbladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Radiation Therapy in Unresectable Gall Bladder Cancer [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating radiation therapy for unresectable gallbladder cancer is currently recruiting at Tata Memorial Centre.
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Clinical Correlation Study Between Anomalous Pancreaticobiliary Ductal Junction and Malignant Tumors of the Biliary System and the Establishment of an AI-based Automated Recognition System
This completed clinical trial investigated the relationship between anomalous pancreaticobiliary ductal junction and malignant tumors of the…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer [Phase 3]
Phase 3 trial evaluating adjuvant chemotherapy with gemcitabine and cisplatin versus standard of care after curative resection of biliary tr…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma [Phase 2]
The document outlines a Phase 2 clinical trial evaluating first-line therapy with camrelizumab and chemotherapy, with or without anlotinib, …
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) [NA]
PLATON, a platform for analyzing targetable tumor mutations, completed its pilot study evaluating its utility across hepatocellular carcinom…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Global Evaluation of Cholecystectomy Knowledge and Outcomes
A completed clinical trial evaluating global knowledge about cholecystectomy and its outcomes. Conditions include gallstone disease, gallbla…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Perioperative Therapy Preoperative Chemotherapy Versus Chemoradiotherapy in Locally Advanced Gall Bladder Cancers [Phase 2, Phase 3]
This is an ongoing phase 2/3 clinical trial evaluating preoperative chemotherapy versus preoperative chemoradiotherapy for locally advanced …
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer [Phase 2]
Phase II study evaluating GemOX hepatic arterial infusion combined with lenvatinib and toripalimab for advanced unresectable intrahepatic ch…
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: First-line Trastuzumab, Gemcitabine, Cisplatin and Nivolumab in Advanced HER2- Positive Biliary Tract Cancer: a Multicenter, Open-label, Single-arm Phase Ib/II Trial (HERBOT) [Phase 1, Phase 2]
A multicenter, open-label Phase Ib/II trial evaluating first-line trastuzumab with gemcitabine and cisplatin plus nivolumab in HER2-positive…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer [Phase 2]
This Phase 2 trial evaluates neoadjuvant gemcitabine plus cisplatin, with or without durvalumab, in patients with resectable biliary tract c…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Donafenib Combined With Capecitabine for Postoperative Adjuvant Therapy of Biliary Malignant Tumors With High-risk Recurrence Risk [Phase 2]
Phase 2 trial evaluating donafenib in combination with capecitabine as postoperative adjuvant therapy for biliary tract cancer with high rec…
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device [NA]
A completed validation trial evaluated removal of EpCAM-positive tumor cells from blood collected during tumor surgery using the Catumaxomab…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab [Phase 1]
Phase 1 trial evaluating dasatinib to prevent oxaliplatin-induced neuropathy in patients with metastatic gastrointestinal cancers receiving …
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms [NA]
This entry notes the completion of a clinical trial evaluating a comprehensive electronic cancer support system for managing cancer-related …
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Diagnostic Value of Next-Generation Sequencing Analysis in Biliary Tract Tumours [NA]
This clinical trial registry entry describes a study evaluating the diagnostic value of next-generation sequencing analysis in biliary tract…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer [Phase 2]
Phase 2 trial evaluating toripalimab in combination with capecitabine as postoperative adjuvant therapy for resectable extrahepatic biliary …
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Neoadjuvant Chemotherapy With Gemcitabine Plus Cisplatin Followed by Radical Liver Resection Versus Immediate Radical Liver Resection Alone With or Without Adjuvant Chemotherapy in Incidentally Detected Gallbladder Carcinoma After Simple Cholecystectomy or in Front of Radical Resection of BTC [Phase 3]
Phase 3 trial comparing neoadjuvant gemcitabine plus cisplatin followed by liver resection versus immediate liver resection (with or without…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP [NA]
A completed clinical trial evaluated the LMA Gastro dual-channel supraglottic airway device for oxygenation during ERCP procedures.
-
CLINICAL_TRIALS research · 2024-11-04Clinical Trial Update: Primary Percutaneous Stenting Above the Ampulla Versus Endoscopic Drainage for Unresectable Malignant Hilar Biliary Obstruction [Phase 3]
A Phase 3 clinical trial comparing primary percutaneous stenting above the ampulla to endoscopic drainage for unresectable malignant hilar b…
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers [Phase 3]
A Phase 3 trial evaluating gemcitabine hydrochloride and cisplatin with or without nab-paclitaxel in newly diagnosed advanced biliary tract …
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA [Phase 2]
Phase 2 clinical trial evaluating a targeted GEMOX therapy with ctDNA monitoring in patients with resectable gallbladder cancer; recruitment…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Outcomes and Prognostic Factors in Hepatopancreatoduodenectomy
A completed clinical trial from Seoul National University Hospital analyzes outcomes and prognostic factors for hepatopancreatoduodenectomy …
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Gemcitabine Hydrochloride, Cisplatin, Nab-Paclitaxel, and Durvalumab in Treating Patients with Locally Advanced or Metastatic Gallbladder Cancer [Phase 2]
Phase 2 clinical trial evaluating a combination of gemcitabine hydrochloride, cisplatin, nab-paclitaxel, and durvalumab for locally advanced…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers [Phase 2]
Phase 2 study of Zanidatamab (ZW25) in advanced or metastatic HER2-amplified biliary tract cancers completed with results posted.
-
CLINICAL_TRIALS research · 2024-08-13Clinical Trial Update: Addition of Everolimus to Standard of Care in Carcinoma Gallbladder [Phase 2, Phase 3]
This document describes a clinical trial evaluating the addition of everolimus to standard of care for gallbladder cancer, across Phase 2 an…